On June 9, Hims & Hers Health rose 5.06% in regular trading, trading at $28.81/share, with trading volume of approximately $101 million. The rally reflects continued market enthusiasm surrounding the company's completed acquisition of Eucalyptus.
On the news front, the company officially completed its acquisition of Australian telehealth firm Eucalyptus on June 2, expanding its business footprint into Australia, Canada, Germany, and other international markets. The deal consolidates its position as the world's largest consumer health platform, with a leading presence across the U.S., U.K., Australia, and Canada, while extending influence into France, Germany, Ireland, Japan, and Spain. The acquisition is expected to strengthen the company's health management service portfolio, particularly in clinically validated weight management programs.
Notably, the company also amended its revolving credit agreement on May 29 to introduce a covenant compliance grace period, ensuring operational flexibility during the post-acquisition integration phase.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments